# Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients

> **NCT02555787** · — · COMPLETED · sponsor: **Astellas Pharma Europe Ltd.** · enrollment: 4430 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT02555787
- **Lead sponsor:** Astellas Pharma Europe Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-05
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 4430 (ACTUAL)
- **Last updated:** 2024-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02555787

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02555787, "Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02555787. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*